| http://www.w3.org/ns/prov#value | - So if I look longer term, it would be that an immunomodulatory drug with a monoclonal antibody targeting, in this case, CD20, would be the play that would get rid of finally these toxic, very old chemotherapies and improve not only response rates and other outcomes but really get rid of toxicity.
|
